10-Q: Bunge Global Q3 2025: Viterra Acquisition Drives Growth

Sentiment:

Quarterly Report 5 November 2025 9:17 PM

Bunge Global SA reports Q3 2025 results, showcasing significant growth in net sales and segment EBIT driven by the Viterra acquisition, despite a decline in net income attributable to shareholders for the quarter.

Delay expectedThe asset purchase agreement with Solae, L.L.C. (International Flavors and Fragrances) is expected to close in 2026, indicating a future closing date.The European margarines and spreads business disposition is expected to close in 2026, subject to customary closing conditions, including regulatory approval.The SEC voluntarily stayed the effective date of the final climate-related disclosure rules pending completion of judicial review.

Capital raiseThe Viterra acquisition was financed through a combination of cash on hand and Bunge's existing debt instruments, including $2.0 billion borrowed under a 3-year tranche term loan and $300 million under a delayed draw term loan in June 2025.Bunge completed the sale and issuance of $1.3 billion aggregate principal amount of 2025 Senior Notes in August 2025.Bunge increased the aggregate size of its existing unsecured corporate commercial paper program by $1.0 billion, from $2.0 billion to $3.0 billion, on September 3, 2025.Bunge entered into new revolving credit agreements in October 2025, increasing total committed capacity to $9,665 million, with accordion provisions allowing for further increases.The company's capital band allows for increasing or reducing share capital by issuing up to 21,249,835 shares or cancelling up to 91,750,795 shares until October 19, 2028.Conditional share capital for employee participation allows for increasing capital by up to 12,914,357 shares.Conditional share capital for financing, acquisitions, or other purposes allows for increasing capital by up to 19,371,537 shares.

Summary

Net income attributable to Bunge shareholders was $166 million for Q3 2025, a decrease of $55 million compared to $221 million in Q3 2024.
For the nine months ended September 30, 2025, net income attributable to Bunge shareholders was $721 million, an increase of $186 million from $535 million in YTD Q3 2024.
Diluted earnings per share was $0.84 for Q3 2025, down from $1.56 in Q3 2024, but increased to $4.60 for YTD Q3 2025 from $3.73 in YTD Q3 2024.
Net sales significantly increased to $22,155 million for Q3 2025 (from $12,908 million in Q3 2024) and to $46,567 million for YTD Q3 2025 (from $39,566 million in YTD Q3 2024), primarily due to the Viterra acquisition.
Total EBIT was $403 million for Q3 2025, a slight decrease from $407 million in Q3 2024, but increased to $1,269 million for YTD Q3 2025 from $1,025 million in YTD Q3 2024.
The Viterra acquisition, completed on July 2, 2025, contributed $8.2 billion to net sales for the three months ended September 30, 2025.
Working capital increased to $10,622 million at September 30, 2025, from $8,523 million at December 31, 2024.
Total debt rose substantially to $15,589 million at September 30, 2025, from $6,238 million at December 31, 2024, mainly due to Viterra acquisition financing.

Sentiment

Score: 6

Explanation: The filing presents a mixed picture. While the Viterra acquisition significantly boosted revenue and year-to-date profitability, it also led to a substantial increase in debt and higher expenses, resulting in a quarterly net income decline. Strategic divestments and credit rating upgrades are positive, but the short-term impact on shareholder net income and the increase in debt warrant a neutral-to-slightly-positive score.

Positives

Net sales for Q3 2025 increased 71.6% to $22,155 million, and YTD Q3 2025 increased 17.7% to $46,567 million, largely driven by the Viterra acquisition.
Year-to-date Net Income attributable to Bunge shareholders increased by $186 million to $721 million.
Year-to-date Diluted EPS increased by $0.87 to $4.60.
Year-to-date Total EBIT increased by $244 million to $1,269 million, primarily due to higher Segment EBIT.
Soybean Processing and Refining Segment EBIT increased 52% to $337 million for Q3 2025 and 131% to $1,068 million for YTD Q3 2025, driven by improved margins in North America and Brazil.
Softseed Processing and Refining Segment EBIT increased 79% to $236 million for Q3 2025, benefiting from higher average sales prices in Europe due to a regional drought impacting the sunflower seed crop.
Grain Merchandising and Milling Segment EBIT increased 10% to $254 million for YTD Q3 2025, boosted by a $155 million gain on the sale of the North America corn milling business.
Successfully completed the Viterra acquisition on July 2, 2025, creating a premier global agribusiness solutions company.
Completed the EU Oilseeds Divestment on September 1, 2025, for $483 million in cash proceeds, fulfilling regulatory commitments.
Credit ratings were upgraded by Standard & Poor's (to A-), Moody's (to Baa1), and Fitch (to BBB+), reflecting an improved credit profile.
Increased quarterly cash dividend distribution to $0.70 per share, representing a 3% increase from the previous quarter.

Negatives

Net income attributable to Bunge shareholders decreased by $55 million to $166 million for Q3 2025 compared to Q3 2024.
Diluted EPS decreased by $0.72 to $0.84 for Q3 2025 compared to Q3 2024.
Total EBIT decreased by $4 million to $403 million for Q3 2025 compared to Q3 2024.
Higher net interest expense for Q3 2025 due to increased debt levels to finance the Viterra acquisition.
Corporate and Other EBIT decreased significantly for both Q3 and YTD Q3 2025, primarily due to higher selling, general and administrative (SG&A) expenses and increased acquisition and integration costs related to Viterra.
Soybean Processing and Refining segment reported foreign exchange losses of $42 million in Q3 2025, a 380% decrease from gains in the prior year.
Softseed Processing and Refining Segment EBIT decreased 36% to $337 million for YTD Q3 2025 due to lower gross profit and margins in European and North American businesses.
Other Oilseeds Processing and Refining Segment EBIT decreased 26% to $77 million for Q3 2025 and 66% to $72 million for YTD Q3 2025, primarily due to lower gross profit in the tropical oils business and less favorable results from the Loders joint venture.
Grain Merchandising and Milling Segment EBIT decreased 73% to $21 million for Q3 2025 due to higher SG&A expenses and unfavorable mark-to-market results.
Cash used for operating activities was $503 million for YTD Q3 2025, a decrease of $1,350 million compared to cash provided in the prior year, driven by net changes in working capital.
Total debt significantly increased by $9,351 million to $15,589 million at September 30, 2025, primarily due to Viterra acquisition financing.
The definitive share purchase agreement for the acquisition of CJ Selecta in Brazil was formally terminated in April 2025.

Risks

Impact of the war in Ukraine and resulting economic sanctions on Russia on operations and facilities.
Effect of weather conditions and the impact of crop and animal disease on the business.
Impact of global and regional economic, agricultural, financial, and commodities market, political, social, and health conditions.
Changes in government policies and laws affecting the business, including agricultural and trade policies (tariffs), financial markets regulation, and environmental, tax, and biofuels regulation.
Impact of seasonality on business operations.
Outcome of pending regulatory and legal proceedings.
Ability to complete, integrate, and benefit from acquisitions, divestitures, joint ventures, and strategic alliances, including the Viterra business combination.
Impact of industry conditions, including fluctuations in supply, demand, and prices for agricultural commodities and other raw materials and products, fluctuations in energy and freight costs, and competitive developments.
Effectiveness of capital allocation plans, funding needs, and financing sources.
Effectiveness of risk management strategies.
Operational risks, including industrial accidents, natural disasters, pandemics or epidemics, wars, and cybersecurity incidents.
Changes in foreign exchange policy or rates.
Impact of dependence on third parties.
Ability to attract and retain executive management and key personnel.
Credit and counterparty risks, including sovereign credit risk, especially during periods of tight global credit markets, economic downturns, and significant price volatility.
Commodities risk due to unpredictable factors like inflationary pressures and counterparty non-performance under forward contracts.
Ocean freight risk due to market price variations depending on vessel supply/demand, global economic conditions, and inflationary pressure.
Energy risk due to volatility in energy costs and inflationary pressures.
Interest rate risk due to changes in interest rates, including inflationary pressures.
Inflation risk affecting labor, overhead costs, and the ability to recover impacts through sales price increases.

Future Outlook

The company expects the 'One Big Beautiful Bill Act' (H.R.1) to not materially impact its consolidated effective tax rate but anticipates additional cash tax benefits by accelerating tax deductions for eligible investments. The European margarines and spreads business disposition and the International Flavors and Fragrances asset purchase are both expected to close in 2026. The remaining U.S. Pension Plan obligation is expected to be settled in the fourth quarter of 2025. The unaudited supplemental pro forma financial information for the Viterra acquisition is not indicative of future operating results, as it does not reflect anticipated synergies, efficiencies, or other cost savings.

Management Comments

The Acquisition of Viterra creates a premier global agribusiness solutions company for food, feed and fuel, well positioned to meet the demands of increasingly complex markets and better serve farmers and end-customers.
Our main financial objectives are to prudently manage financial risks, ensure consistent access to liquidity and minimize cost of capital in order to efficiently finance our business and maintain balance sheet strength.
Management believes that the condensed consolidated financial statements reflect the largest amount of tax benefit that is more likely than not to be realized.
The Company currently expects that it will not have a material impact on its consolidated effective tax rate [from H.R.1].
We have historically been able to recover the impacts of inflation through sales price increases, however we cannot reasonably estimate our ability to successfully recover any impact of inflation through price increases in the future.

Industry Context

The Viterra acquisition significantly enhances Bunge's position as a global agribusiness leader, expanding its reach in food, feed, and fuel markets. Regional factors, such as a drought in Europe, influenced softseed prices, while global biofuel mandates drove demand and prices in the tropical oils business. Trade dynamics, including increased corn exports from North America and wheat demand from China, impacted grain merchandising volumes. The termination of the CJ Selecta acquisition in Brazil suggests a dynamic and potentially challenging M&A landscape in certain regions, while strategic divestments indicate a focus on portfolio optimization.

Comparison to Industry Standards

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Segment Reporting Structure	Effective July 1, 2025, the company changed its reportable segments to align with its new value chain operational structure following the Viterra acquisition.	July 1, 2025	Enhances alignment of reporting with new operational structure and primary income-generating activities post-acquisition.
Segment Reclassification	Effective January 1, 2025, Bunge's Sugar and Bioenergy reporting segment was reclassified to Corporate and Other.	January 1, 2025	Streamlines reporting by consolidating a previously separate segment into a broader category, reflecting strategic shifts.
Articles of Association Amendment	Articles of Association were amended to reflect changes related to the capital band, conditional share capital, and shareholder access to proxy materials.	July 1, 2025	Provides greater flexibility for capital management and clarifies shareholder rights and nomination processes.
Share Repurchase Program Expansion	The Board of Directors approved the expansion of an existing share repurchase program by an additional $500 million, bringing total authorizations to $2.7 billion.	November 13, 2024	Indicates management's confidence and commitment to returning capital to shareholders, potentially boosting shareholder value.
Dividend Approval	Shareholders approved a cash dividend distribution of $2.80 per share, payable in four equal quarterly installments of $0.70 per share.	May 15, 2025	Demonstrates a commitment to consistent shareholder returns, with a 3% increase in the quarterly dividend.
Compliance with Financial Covenants	The company was in compliance with specified financial covenants (minimum current ratio, maximum debt to capitalization ratio, limitations on secured indebtedness) as of September 30, 2025.	September 30, 2025	Maintains financial stability and access to credit facilities, reassuring creditors and investors despite increased debt levels.

Legal Proceedings

Party to claims and lawsuits, primarily from indemnities provided to third parties and labor claims in South America, arising in the normal course of business.
Involved in various contract, antitrust, environmental litigation and remediation, and other litigation, claims, government investigations, and legal proceedings.
Recognized a liability of $95 million related to indemnities for the sale of BP Bunge Bioenergia, with maximum potential future payments of $1,357 million.
Recognized a $9 million obligation related to indemnity for the disposition of Russian operations, with maximum potential future payments of $235 million.
Brazilian indirect tax claims (ICMS, PIS/COFINS) totaling $160 million (ICMS) and $515 million (PIS/COFINS) as of September 30, 2025.
Labor claims, principally against Brazilian subsidiaries, totaling $38 million as of September 30, 2025, related to dismissals, severance, health and safety, salary adjustments, and supplementary retirement benefits.
Civil and other claims totaling $286 million as of September 30, 2025, related to various disputes and indemnities with third parties, including suppliers, customers, and buyers.
Management does not expect these matters to have a material adverse effect on financial condition, results of operations, or liquidity, but acknowledges a remote possibility of material adverse impact if liabilities substantially exceed provisions.

Related Party Transactions

Purchases of agricultural commodity products from unconsolidated investees and other related parties comprised approximately 9% or less of total Cost of goods sold for the three and nine months ended September 30, 2025, and 2024.
Sales of agricultural commodity products to unconsolidated investees and other related parties comprised approximately 2% or less of total Net sales for the three and nine months ended September 30, 2025, and 2024.
Services received from and provided to unconsolidated investees and other related parties (tolling, port handling, administrative support) were not material.
Receivables related to related party transactions comprised approximately 4% or less of total Trade accounts receivable at September 30, 2025, and December 31, 2024.
Payables related to related party transactions comprised approximately 3% or less of total Trade accounts payable at September 30, 2025, and December 31, 2024.
Advances to unconsolidated investees comprised approximately 3% or less of total Other current assets and 6% or less of total Other non-current assets at September 30, 2025, and December 31, 2024.
Management believes all transaction values to be similar to those conducted with third parties at arm's-length.

Stakeholder Impact

Shareholders are impacted by the Viterra acquisition (dilution from share issuance, potential long-term growth, increased debt), the ongoing share repurchase program, and the increased quarterly dividends.
Employees are affected by the integration of Viterra, which may lead to organizational changes and potential synergies.
Customers may benefit from Bunge's expanded global presence and diversified offerings as a 'premier global agribusiness solutions company'.
Suppliers, particularly farmers in Brazil, continue to receive secured advances, indicating ongoing business relationships.
Creditors face increased exposure due to higher debt levels from the Viterra acquisition, but credit rating upgrades and compliance with financial covenants provide reassurance.

Next Steps

Finalize purchase price adjustments for the Viterra acquisition within approximately six months of the acquisition date (by early 2026).
Complete the asset purchase of International Flavors and Fragrances' lecithin, soy protein concentrate, and crush businesses in 2026.
Complete the sale of the European margarines and spreads business in 2026, subject to regulatory approval.
Provide preliminary purchase price allocation for the ViOil acquisition in future filings.
Settle the remaining U.S. Pension Plan obligation in the fourth quarter of 2025.
Continue to evaluate the impact of ASU 2024-03 on consolidated financial statements.
Monitor the status of ongoing litigation regarding SEC climate-related disclosure rules.
Evaluate disclosure presentation alternatives for ASU 2023-09, which is effective for annual periods beginning after December 15, 2024.
The Board will determine the use of the reduction amount in case of a share capital reduction within the capital band.

Key Dates

Date	Description
October 10, 2023	Bunge entered into a definitive share purchase agreement to acquire CJ Latam Participaes Ltda. and CJ Selecta S.A.
January 2024	Bunge and Varthomio entered into a share purchase agreement for Bunge to acquire a 15% equity interest and a fixed price call option for the remaining 85% equity interest in ViOil, an oilseed crush operation in western Ukraine.
March 26, 2024	Bunge entered into a definitive stock purchase agreement with Repsol Industrial Transformation, SLU, to divest 40% of its Spanish operating subsidiary, Bunge Iberica SA (BISA).
April 4, 2024	The SEC voluntarily stayed the effective date of the final climate-related disclosure rules pending completion of judicial review.
June 19, 2024	Bunge entered into a definitive share purchase agreement with BP Biofuels Brazil Investment Limited to sell its 50% ownership share in BP Bunge Bioenergia.
August 1, 2024	Moody's upgraded Bunge's long-term debt credit rating to Baa1 with a stable outlook.
September 5, 2024	Fitch upgraded Bunge's long-term debt credit rating to BBB+ with a stable outlook.
September 9, 2024	Bunge's wholly-owned subsidiary, BLFC, commenced offers to exchange outstanding notes of Viterra Finance B.V. for new notes issued by BLFC.
September 17, 2024	Bunge completed the sale and issuance of $2.0 billion aggregate principal amount of Senior Notes.
October 1, 2024	Transaction closed for the sale of Bunge's 50% ownership share in BP Bunge Bioenergia to BP for a total net amount of $828 million.
November 13, 2024	Bunge Global SA's Board of Directors approved the expansion of an existing share repurchase program by an additional $500 million, bringing total authorizations to $2.7 billion.
November 2024	Bunge exercised the option to acquire the remaining interest in Terminal de Granis de Santa Catarina (TGSC).
December 2024	The FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740).
January 1, 2025	Bunge's Sugar and Bioenergy reporting segment was reclassified to Corporate and Other.
March 4, 2025	Transaction closed for the sale of 40% of Bunge Iberica SA (BISA) to Repsol for approximately $206 million in cash and $80 million in deferred consideration.
March 21, 2025	Bunge entered into an agreement to sell its European margarines and spreads business to Vandemoortele Lipids NV for approximately $239 million.
March 2025	The SEC voted to end its defense of the climate-related disclosure rules.
April 2025	The definitive share purchase agreement between Bunge and CJ with respect to the acquisition of CJ Selecta was formally terminated.
April 8, 2025	Bunge entered into an agreement to sell substantially all of its corn milling business in North America to Grain Craft, LLC.
May 15, 2025	Shareholders of Bunge Global SA approved a cash dividend distribution of $2.80 per share, payable in four equal quarterly installments of $0.70 per share.
June 20, 2025	Bunge formally exercised the call option to acquire the remaining interest in ViOil.
June 30, 2025	Transaction closed for the sale of Bunge's North America corn milling business to Grain Craft, LLC.
June 30, 2025	Bunge borrowed $2.0 billion under a 3-year tranche term loan and $300 million under a delayed draw term loan to finance the Viterra acquisition.
July 1, 2025	Effective date for change in segment reporting to align with new value chain operational structure post-Viterra acquisition.
July 2, 2025	Bunge completed its acquisition of Viterra Limited.
July 2, 2025	Standard & Poor's upgraded Bunge's credit rating to Aand assigned a stable outlook.
July 2, 2025	Fitch affirmed Bunge's long-term debt credit rating to BBB+ with a stable outlook.
July 4, 2025	H.R.1, commonly known as the 'One Big Beautiful Bill Act', was signed into U.S. law.
August 4, 2025	Bunge completed the sale and issuance of $1.3 billion aggregate principal amount of 2025 Senior Notes.
August 5, 2025	Bunge entered into an asset purchase agreement with Solae, L.L.C. to acquire substantially all assets related to the lecithin, soy protein concentrate and crush businesses of International Flavors and Fragrances, Inc.
September 1, 2025	Bunge completed the EU Oilseeds Divestment, selling Viterra's business in Hungary and part of its business in Poland.
September 2, 2025	Bunge paid a regular quarterly cash dividend distribution of $0.70 per share.
September 3, 2025	Bunge increased the aggregate size of its existing unsecured corporate commercial paper program by $1.0 billion, from $2.0 billion to $3.0 billion.
Q3 2025	BLFC completed the US Exchange Offers, exchanging $1.92 billion of Existing USD Viterra Notes for new notes.
Q3 2025	Bunge completed the amendment of indentures governing VFBV's outstanding Euro notes (European Consent Solicitation).
September 2025	The 0.375% Senior Note Due 2025 Euro were fully repaid.
September 30, 2025	End of the quarterly period covered by this report.
October 3, 2025	Bunge entered into an unsecured $4.2 billion 5-year revolving credit agreement, replacing an existing $3.2 billion agreement.
October 3, 2025	Bunge entered into an unsecured $3.5 billion 3-year revolving agreement, replacing an existing $3.5 billion agreement.
October 3, 2025	Bunge entered into an unsecured $1.1 billion 364-day revolving credit agreement, replacing an existing $1.1 billion agreement.
October 3, 2025	Bunge amended and restated the $865 million revolving credit facility, extending maturity to October 3, 2030.
October 29, 2025	Bunge repaid $1.0 billion of the $2.0 billion Term Loan due 2028 using proceeds from other corporate credit facilities.
October 2025	The Company completed $119 million of disbursements to U.S. Pension Plan participants electing a lump sum buyout.
Early Q4 2025	The ViOil acquisition transaction closed.
2026	Expected closing of the asset purchase of International Flavors and Fragrances' lecithin, soy protein concentrate, and crush businesses.
2026	Expected closing of the European margarines and spreads business disposition.
Fiscal years beginning after December 15, 2026	Effective date for ASU 2024-03, Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Subtopic 220-40).
Interim reporting periods within fiscal years beginning after December 15, 2027	Effective date for interim reporting periods for ASU 2024-03.
October 19, 2028	Expiration of the capital band authorization.
October 3, 2028	Maturity date for the $3.5 Billion Revolving Agreement.
2029	Expiration of residual value guarantees for certain operating lease arrangements.
February 2030	Expiration of the indemnity related to the disposition of Bunge's Russian operations.
October 3, 2030	Maturity date for the $4.2 Billion Revolving Credit Agreement.
October 3, 2030	Maturity date for the $865 Million Revolving Loan Facility.
May 17, 2031	Termination date for the trade receivables securitization program.
2041	Maturity dates for guarantees related to debt of certain unconsolidated affiliates.

Recommendation

hold

The Viterra acquisition is a transformative event, significantly expanding Bunge's scale and market position. While the year-to-date financial performance shows strong growth in sales and EBIT, the immediate quarter's net income decline and the substantial increase in debt introduce short-term uncertainties and integration risks. The credit rating upgrades are positive, but the full benefits and synergies of the acquisition are yet to be realized and proven. Investors should hold to observe the successful integration of Viterra, the realization of anticipated synergies, and the management of the increased debt load before making further investment decisions. The termination of the CJ Selecta acquisition also highlights potential challenges in certain growth strategies.

Keywords

Agribusiness, Commodities, Viterra Acquisition, Soybean Processing, Softseed Processing, Grain Merchandising, Milling, SEC Filing, Financial Results, Q3 2025, Earnings, Debt, Working Capital, Risk Management, Corporate Governance, Sustainability, Bioenergy

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.